Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes

Cancer immunotherapy is ineffective in a subset of patients. Here the authors show that, in a mouse model of melanoma, resistance to immune checkpoint inhibitors relies on loss of tumor-specific T cells through FasL-mediated apoptosis triggered by polymorphonuclear-myeloid-derived suppressor cells.

Guardado en:
Detalles Bibliográficos
Autores principales: Jingjing Zhu, Céline G. Powis de Tenbossche, Stefania Cané, Didier Colau, Nicolas van Baren, Christophe Lurquin, Anne-Marie Schmitt-Verhulst, Peter Liljeström, Catherine Uyttenhove, Benoit J. Van den Eynde
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/03b05d3e6ab641c1b1de96121c6dfbee
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:03b05d3e6ab641c1b1de96121c6dfbee
record_format dspace
spelling oai:doaj.org-article:03b05d3e6ab641c1b1de96121c6dfbee2021-12-02T15:38:58ZResistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes10.1038/s41467-017-00784-12041-1723https://doaj.org/article/03b05d3e6ab641c1b1de96121c6dfbee2017-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00784-1https://doaj.org/toc/2041-1723Cancer immunotherapy is ineffective in a subset of patients. Here the authors show that, in a mouse model of melanoma, resistance to immune checkpoint inhibitors relies on loss of tumor-specific T cells through FasL-mediated apoptosis triggered by polymorphonuclear-myeloid-derived suppressor cells.Jingjing ZhuCéline G. Powis de TenbosscheStefania CanéDidier ColauNicolas van BarenChristophe LurquinAnne-Marie Schmitt-VerhulstPeter LiljeströmCatherine UyttenhoveBenoit J. Van den EyndeNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-15 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Jingjing Zhu
Céline G. Powis de Tenbossche
Stefania Cané
Didier Colau
Nicolas van Baren
Christophe Lurquin
Anne-Marie Schmitt-Verhulst
Peter Liljeström
Catherine Uyttenhove
Benoit J. Van den Eynde
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
description Cancer immunotherapy is ineffective in a subset of patients. Here the authors show that, in a mouse model of melanoma, resistance to immune checkpoint inhibitors relies on loss of tumor-specific T cells through FasL-mediated apoptosis triggered by polymorphonuclear-myeloid-derived suppressor cells.
format article
author Jingjing Zhu
Céline G. Powis de Tenbossche
Stefania Cané
Didier Colau
Nicolas van Baren
Christophe Lurquin
Anne-Marie Schmitt-Verhulst
Peter Liljeström
Catherine Uyttenhove
Benoit J. Van den Eynde
author_facet Jingjing Zhu
Céline G. Powis de Tenbossche
Stefania Cané
Didier Colau
Nicolas van Baren
Christophe Lurquin
Anne-Marie Schmitt-Verhulst
Peter Liljeström
Catherine Uyttenhove
Benoit J. Van den Eynde
author_sort Jingjing Zhu
title Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
title_short Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
title_full Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
title_fullStr Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
title_full_unstemmed Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
title_sort resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/03b05d3e6ab641c1b1de96121c6dfbee
work_keys_str_mv AT jingjingzhu resistancetocancerimmunotherapymediatedbyapoptosisoftumorinfiltratinglymphocytes
AT celinegpowisdetenbossche resistancetocancerimmunotherapymediatedbyapoptosisoftumorinfiltratinglymphocytes
AT stefaniacane resistancetocancerimmunotherapymediatedbyapoptosisoftumorinfiltratinglymphocytes
AT didiercolau resistancetocancerimmunotherapymediatedbyapoptosisoftumorinfiltratinglymphocytes
AT nicolasvanbaren resistancetocancerimmunotherapymediatedbyapoptosisoftumorinfiltratinglymphocytes
AT christophelurquin resistancetocancerimmunotherapymediatedbyapoptosisoftumorinfiltratinglymphocytes
AT annemarieschmittverhulst resistancetocancerimmunotherapymediatedbyapoptosisoftumorinfiltratinglymphocytes
AT peterliljestrom resistancetocancerimmunotherapymediatedbyapoptosisoftumorinfiltratinglymphocytes
AT catherineuyttenhove resistancetocancerimmunotherapymediatedbyapoptosisoftumorinfiltratinglymphocytes
AT benoitjvandeneynde resistancetocancerimmunotherapymediatedbyapoptosisoftumorinfiltratinglymphocytes
_version_ 1718385971047694336